Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Asset Utilization Ratio (2016 - 2025)

Arrowhead Pharmaceuticals' Asset Utilization Ratio history spans 15 years, with the latest figure at 0.73 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 31335.92% year-over-year to 0.73; the TTM value through Dec 2025 reached 0.73, up 31335.92%, while the annual FY2025 figure was 0.66, 17525.28% up from the prior year.
  • Asset Utilization Ratio reached 0.73 in Q4 2025 per ARWR's latest filing, up from 0.6 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.73 in Q4 2025 to a low of 0.0 in Q4 2024.
  • Average Asset Utilization Ratio over 5 years is 0.28, with a median of 0.3 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 99.11% in 2024, then skyrocketed 31335.92% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.21 in 2021, then surged by 64.15% to 0.35 in 2022, then fell by 25.72% to 0.26 in 2023, then tumbled by 99.11% to 0.0 in 2024, then soared by 31335.92% to 0.73 in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Asset Utilization Ratio are 0.73 (Q4 2025), 0.6 (Q3 2025), and 0.39 (Q2 2025).